2025-08-20 - Analysis Report
Okay, here's a comprehensive report on Colgate-Palmolive Co (CL), incorporating the data you provided:

## Colgate-Palmolive Co (CL) Stock Analysis

**Company Overview:** Colgate-Palmolive Co (CL) is a global consumer products company focusing on oral care, personal care, home care, and pet nutrition.

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return (CL):** 11.87%
*   **Cumulative Return (VOO):** 100.85%
*   **Absolute Deviation:** -74.1
*   **Deviation Range (Min: -75.2, Max: 8.5):**
*   **Relative Deviation:** 1.3

**Analysis:** CL has significantly underperformed the S&P 500 (VOO) over the period examined. The relative deviation of 1.3 indicates that CL's underperformance is near the extreme end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha   | Beta  | Cap(B) |
|------------|----------|----------|---------|-------|--------|
| 2015-2017  | 13.0%    | 4.5%     | -16.0%  | 0.0   | 62.1   |
| 2016-2018  | -11.0%   | 65.2%    | -29.0%  | 0.1   | 49.0   |
| 2017-2019  | 7.0%     | 65.2%    | -22.0%  | 0.1   | 56.7   |
| 2018-2020  | 18.0%    | 65.2%    | -2.0%   | 0.6   | 70.4   |
| 2019-2021  | 30.0%    | 58.6%    | -19.0%  | 0.7   | 70.3   |
| 2020-2022  | 7.0%     | 69.0%    | 5.0%    | 0.7   | 64.9   |
| 2021-2023  | 6.0%     | 69.0%    | -12.0%  | 0.8   | 65.6   |
| 2022-2024  | 13.0%    | 69.0%    | -12.0%  | 0.8   | 74.9   |
| 2023-2025  | -1.0%    | 70.6%    | -54.0%  | 0.3   | 69.4   |

**Analysis:**

*   **Alpha:** Consistently negative alpha suggests underperformance compared to the benchmark, especially in recent periods. This means CL is not generating excess returns relative to its risk.
*   **Beta:** Low beta values indicate that CL is less volatile than the overall market (S&P 500). Beta has been increasing recently, suggesting a slightly stronger correlation with the market.
*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows fluctuating growth rates over different periods.
*   **MDD:** The Maximum Drawdown (MDD) indicates the maximum loss from a peak to a trough during a specific period. High MDD values indicate significant risk.
*   **Cap:** Market capitalization of the company, measured in billions.

### 2. Recent Stock Price Movement

*   **Current Price:** 85.85
*   **Previous Close:** 84.26
*   **Change:** 1.89 (Increase)
*   **5-Day Moving Average:** 85.06
*   **20-Day Moving Average:** 85.53
*   **60-Day Moving Average:** 88.69

**Analysis:**

The stock price has increased compared to the previous close, and is slightly above the 5-day and 20-day moving averages. However, it's still below the 60-day moving average, which might indicate a recent downtrend.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.329 (Low Risk)
*   **RSI:** 37.64 (Approaching Oversold)
*   **PPO:** 0.18
*   **Hybrid Signal:** Sell 69.9% of holdings (1169 shares) due to MRI. (Cash Ratio: 70% on 2025-07-16)
*   **Delta_Previous_Relative_Divergence:** 0.1 (Positive - Short-term increase)
*   **Expected Return (%):** -1964.9 (Significant underperformance vs S&P 500 over the long term)

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests low market risk.
*   **RSI:** The Relative Strength Index is approaching oversold territory, potentially indicating a buying opportunity.
*   **PPO:** The Percentage Price Oscillator is positive, suggesting a slight upward trend.
*   **Hybrid Signal:** The hybrid signal recommends selling a significant portion of the holdings, influenced by the MRI.
*   **Delta_Previous_Relative_Divergence:** The positive change in relative divergence suggests a short-term upward trend.
*   **Expected Return:** The extremely negative expected return signals significant underperformance against the S&P 500 for long-term investment.
*   **Rapid Price Movement:** The significant change in price suggests that market participants should monitor the stock closely due to potential volatility.

### 4. Recent News & Significant Events

*   **[2025-08-17]:** Major business developments, regulatory changes, or market events.
*   **[2025-08-19]:** Analyst discussions regarding performance and outlook amidst industry trends and economic factors.
*   **[2025-08-16]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-08-20]:** Market experts highlighting risks and opportunities, advising investors to monitor news and announcements.

**Analysis:**

The recent news indicates that Colgate-Palmolive Co (CL) has been subject to business developments, regulatory changes, or market events, which has resulted in stock volatility. Analysts are actively discussing Colgate-Palmolive Co’s performance and outlook. Investors are advised to closely monitor the recent news and company announcements.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-08-01 | 0.92 | 5.11 B$   |
| 2025-04-25 | 0.85 | 4.91 B$   |
| 2024-10-25 | 0.9  | 5.03 B$   |
| 2024-07-26 | 0.89 | 5.06 B$   |
| 2025-08-01 | 0.89 | 5.06 B$   |

**Analysis:**

*   Earnings per share (EPS) has fluctuated, with a recent increase.
*   Revenue has shown some variability but remains relatively stable.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-06-30 | $5.11B   | 60.06%        |
| 2025-03-31 | $4.91B   | 60.82%        |
| 2024-12-31 | $4.95B   | 60.30%        |
| 2024-09-30 | $5.03B   | 61.08%        |
| 2024-06-30 | $5.06B   | 60.62%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE        |
|------------|---------|------------|
| 2025-06-30 | $0.70B  | 105.84%    |
| 2025-03-31 | $0.36B  | 190.08%    |
| 2024-12-31 | $0.21B  | 348.58%    |
| 2024-09-30 | $0.43B  | 169.43%    |
| 2024-06-30 | $0.12B  | 594.31%    |

**Analysis:**

*   **Revenue:** Revenue has been relatively consistent across the reported quarters, with a slight increase in the most recent quarter.
*   **Profit Margin:** Profit margins have remained high, indicating strong profitability.
*   **Equity:** Equity has varied across the quarters, but generally remains low.
*   **ROE:** The Return on Equity (ROE) values are extremely high, suggesting very efficient use of equity to generate profits. However, these high ROE values may also be a result of the relatively low equity base, suggesting that the company is not holding a lot of assets on its balance sheet.

### 7. Overall Summary

Based on the provided data:

*   **Underperformance:** CL has significantly underperformed the S&P 500, with a negative alpha suggesting it's not generating excess returns relative to its risk.
*   **Low Volatility:** CL exhibits lower volatility than the market.
*   **Financial Health:** The company maintains good profitability, as evidenced by high-profit margins. However, the ROE values are inflated due to a low equity base.
*   **Technical Indicators:** The RSI is approaching oversold, while the MRI indicates low market risk. The hybrid signal recommends selling a significant portion of holdings based on the MRI.
*   **Recent News:** Recent news indicates volatility and scrutiny of the company's performance.

**Conclusion:**

Colgate-Palmolive Co (CL) appears to be a stable, low-volatility stock, but it has significantly underperformed the broader market. While the company is profitable, the high ROE values may be a result of the low equity base. Investors should carefully consider the underperformance relative to the S&P 500, analyst recommendations, and recent news events before making investment decisions.

